Andrew Welch

Andrew Welch , DO

Assistant Professor of Clinical

Medical Sciences Building

COM IM Endocrinology Division - 0547

Education

BS: Brigham Young University Provo, UT, 2013 (Neuroscience)

DO: Arizona College of Osteopathic Medicine Glendale, AZ, 2020

Certifications

American Board of Internal Medicine (Certification Date: 08-20-2020 )

American Board of Internal Medicine (Endocrinology-Diabetes and Metabolism) (Certification Date: 10-24-2023 )

Clinical Interests

Diabetes

Diabetes Mellitus

Diabetes Type 1 (Diabetes Mellitus, Type 1)

Diabetes Type 2 (Diabetes Mellitus, Type 2)

Diabetic Foot

Diabetic Hypoglycemia

Diabetic Ketoacidosis

Diabetic Nephropathy

Diabetic Neuropathies

Thyroid Cancer

Adrenal Insufficiency

Adrenocortical Adenoma

Cushing syndrome (Hypercortisolism)

Hyperparathyroidism

Hyperthyroidism

Hypothyroidism (Underactive thyroid)

Obesity

Osteoporosis

Pituitary Adenoma

Prolactinoma

Specialities

Endocrinology-Diabetes and Metabolism

Internal Medicine

Publications

Peer Reviewed Publications

Welch, Andrew A; Farahani, Rahele A; Egan, Aoife M; Laurenti, Marcello C; Zeini, Maya; Vella, Max; Bailey, Kent R; Cobelli, Claudio; Dalla Man, Chiara Dalla; Matveyenko, Aleksey; Vella, Adrian (2023. ) The effect of Glucagon-Like Peptide-1 Receptor blockade on islet secretion and glucose metabolism in humans.The Journal of clinical investigation, , More Information

Schembri Wismayer, Daniel; Laurenti, Marcello C; Song, Yilin; Egan, Aoife M; Welch, Andrew A; Bailey, Kent R; Cobelli, Claudio; Dalla Man, Chiara; Jensen, Michael D; Vella, Adrian (2023. ) Effects of acute changes in fasting glucose and free fatty acid concentrations on indices of β-cell function and glucose metabolism in subjects without diabetes.American journal of physiology. Endocrinology and metabolism, , 325 (2 ) ,E119-E131 More Information

Farahani, Rahele A; Egan, Aoife M; Welch, Andrew A; Laurenti, Marcello C; Cobelli, Claudio; Dalla Man, Chiara; Vella, Adrian (2023. ) The Effect of Glucagon-Like Peptide 1 Receptor Blockade on Glucagon-Induced Stimulation of Insulin Secretion.Diabetes, , 72 (4 ) ,449-454 More Information

Brar, Gurkirat S; Barrow, Breanne M; Watson, Matthew; Griesbach, Ryan; Choung, Edwina; Welch, Andrew; Ruzsicska, Bela; Raleigh, Daniel P; Zraika, Sakeneh (2017. ) Neprilysin Is Required for Angiotensin-(1-7)'s Ability to Enhance Insulin Secretion via Its Proteolytic Activity to Generate Angiotensin-(1-2).Diabetes, , 66 (8 ) ,2201-2212 More Information